Seizert Capital Partners LLC cut its holdings in Phibro Animal Health Corp (NASDAQ:PAHC) by 30.3% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 32,419 shares of the company’s stock after selling 14,105 shares during the quarter. Seizert Capital Partners LLC’s holdings in Phibro Animal Health were worth $1,391,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. BlueMountain Capital Management LLC increased its stake in shares of Phibro Animal Health by 60.4% during the second quarter. BlueMountain Capital Management LLC now owns 22,454 shares of the company’s stock worth $1,034,000 after acquiring an additional 8,451 shares during the period. Alps Advisors Inc. acquired a new position in shares of Phibro Animal Health during the second quarter worth about $431,000. First Trust Advisors LP increased its stake in shares of Phibro Animal Health by 20.0% during the second quarter. First Trust Advisors LP now owns 22,586 shares of the company’s stock worth $1,040,000 after acquiring an additional 3,769 shares during the period. BlackRock Inc. increased its stake in shares of Phibro Animal Health by 7.7% during the second quarter. BlackRock Inc. now owns 3,304,441 shares of the company’s stock worth $152,169,000 after acquiring an additional 235,932 shares during the period. Finally, Janus Henderson Group PLC acquired a new position in shares of Phibro Animal Health during the second quarter worth about $222,000. Institutional investors own 48.33% of the company’s stock.

Shares of PAHC opened at $34.20 on Wednesday. The company has a current ratio of 3.26, a quick ratio of 1.82 and a debt-to-equity ratio of 1.62. Phibro Animal Health Corp has a twelve month low of $32.05 and a twelve month high of $54.62. The stock has a market cap of $1.37 billion, a price-to-earnings ratio of 19.66, a P/E/G ratio of 2.91 and a beta of 0.82.

Phibro Animal Health (NASDAQ:PAHC) last issued its earnings results on Tuesday, November 6th. The company reported $0.39 earnings per share for the quarter, missing the consensus estimate of $0.42 by ($0.03). Phibro Animal Health had a return on equity of 38.91% and a net margin of 7.89%. The company had revenue of $200.20 million for the quarter, compared to analyst estimates of $203.99 million. During the same quarter in the previous year, the company posted $0.38 earnings per share. The company’s quarterly revenue was up 3.5% compared to the same quarter last year. Equities analysts anticipate that Phibro Animal Health Corp will post 1.72 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, December 19th. Shareholders of record on Wednesday, November 28th will be given a dividend of $0.12 per share. This is a positive change from Phibro Animal Health’s previous quarterly dividend of $0.10. This represents a $0.48 annualized dividend and a yield of 1.40%. The ex-dividend date of this dividend is Tuesday, November 27th. Phibro Animal Health’s dividend payout ratio is presently 22.99%.

In other Phibro Animal Health news, insider Jack Bendheim sold 20,000 shares of the company’s stock in a transaction dated Thursday, September 6th. The shares were sold at an average price of $47.14, for a total transaction of $942,800.00. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Dean J. Warras sold 10,000 shares of the company’s stock in a transaction dated Thursday, November 1st. The stock was sold at an average price of $42.84, for a total transaction of $428,400.00. Following the transaction, the insider now owns 10,000 shares in the company, valued at $428,400. The disclosure for this sale can be found here. Insiders have sold 83,020 shares of company stock worth $3,977,971 over the last 90 days. 50.29% of the stock is currently owned by company insiders.

A number of research analysts have recently issued reports on PAHC shares. Zacks Investment Research lowered shares of Phibro Animal Health from a “hold” rating to a “sell” rating in a research note on Wednesday, August 29th. BidaskClub upgraded shares of Phibro Animal Health from a “sell” rating to a “hold” rating in a research note on Tuesday, October 16th. Morgan Stanley boosted their price target on shares of Phibro Animal Health from $36.00 to $46.00 and gave the stock an “underweight” rating in a research note on Wednesday, August 29th. Finally, ValuEngine lowered shares of Phibro Animal Health from a “buy” rating to a “hold” rating in a research note on Monday, November 12th. Three analysts have rated the stock with a sell rating and three have issued a hold rating to the stock. The company currently has an average rating of “Hold” and an average target price of $43.50.

COPYRIGHT VIOLATION NOTICE: This report was published by Daily Political and is the sole property of of Daily Political. If you are accessing this report on another domain, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The correct version of this report can be accessed at https://www.dailypolitical.com/2018/11/21/seizert-capital-partners-llc-sells-14105-shares-of-phibro-animal-health-corp-pahc.html.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.

Recommended Story: Marijuana Stocks Investing Considerations

Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Corp (NASDAQ:PAHC).

Institutional Ownership by Quarter for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.